AAPG
Ascentage Pharma Group International
14.60$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.7% | 15.6% | 15.6% | 1.8% | 1.8% | 8.9% | 8.9% | 8.9% | 9.3% | 20.6% | 20.6% | 16.1% | 17.2% | |
| 87.3% | 84.4% | 84.4% | 98.2% | 98.2% | 91.1% | 91.1% | 91.1% | 90.7% | 79.4% | 79.4% | 83.9% | 82.8% | |
| 217.1% | 500.9% | 500.9% | 53.9% | 53.9% | 320.7% | 320.7% | 320.7% | 226.2% | 175.8% | 175.8% | 227.1% | 198.4% | |
| 64.0% | 113.0% | 113.2% | 10.6% | 10.6% | 63.7% | 63.7% | 63.8% | 42.7% | – | – | – | – | |
| 325.9% | 755.5% | 755.5% | 75.4% | 75.4% | 452.3% | 452.3% | 452.3% | 327.8% | 271.2% | 271.2% | 332.8% | 297.6% | |
| -238.7% | -671.1% | -671.1% | 22.8% | 22.8% | -361.2% | -361.2% | -361.2% | -237.1% | -191.8% | -191.8% | -248.9% | -214.8% | |
| 53.1% | – | 25.6% | – | 3.4% | – | – | – | – | 7.7% | 7.7% | 8.9% | – | |
| -280.0% | -672.6% | -672.6% | 19.8% | 19.8% | -355.7% | -355.7% | -355.7% | -250.5% | -191.2% | -191.2% | -265.8% | -221.3% | |
| 1.9% | -12.5% | -12.5% | 0.0% | 0.0% | 6.6% | 6.6% | 6.6% | 2.4% | 0.4% | 0.4% | 4.5% | 1.8% | |
| -282.0% | -660.0% | -660.0% | 19.8% | 19.8% | -362.3% | -362.3% | -362.3% | -252.8% | -191.5% | -191.5% | -270.2% | -223.0% | |
| -175.9% | -621.4% | -621.4% | 27.9% | 27.9% | -336.8% | -336.8% | -336.8% | -219.9% | -179.3% | -179.3% | -234.6% | -200.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.